Found 2 results
Author Title [ Type
] Year Filters: Keyword is Drug Screening Assays, Antitumor [Clear All Filters]
. (2015). Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models. Cancer Res, 75(12), 2489-500. presented at the 2015 Jun 15. doi:10.1158/0008-5472.CAN-14-3167
. (2010). Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4. J Med Chem, 53(1), 325-34. presented at the 2010 Jan 14. doi:10.1021/jm901268n